These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12671515)

  • 1. A rat model for testing pharmacologic treatments of pressure-related bone loss.
    Astrand J; Skripitz R; Skoglund B; Aspenberg P
    Clin Orthop Relat Res; 2003 Apr; (409):296-305. PubMed ID: 12671515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.
    Astrand J; Aspenberg P
    J Orthop Res; 2004 Mar; 22(2):244-9. PubMed ID: 15013081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate did not inhibit instability-induced bone resorption. A study in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 1999 Feb; 70(1):67-70. PubMed ID: 10191752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
    Altundal H; Sayrak H; Yurtsever E; Göker K
    J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-induced periprosthetic osteolysis: a rat model.
    Skripitz R; Aspenberg P
    J Orthop Res; 2000 May; 18(3):481-4. PubMed ID: 10937637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
    Aspenberg P; Agholme F; Magnusson P; Fahlgren A
    Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
    Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
    Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of alendronate on resorption of the alveolar bone following tooth extraction.
    Altundal H; Güvener O
    Int J Oral Maxillofac Surg; 2004 Apr; 33(3):286-93. PubMed ID: 15287313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits.
    Sugata Y; Sotome S; Yuasa M; Hirano M; Shinomiya K; Okawa A
    J Bone Joint Surg Br; 2011 Apr; 93(4):510-6. PubMed ID: 21464492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption.
    Onyia JE; Galvin RJ; Ma YL; Halladay DL; Miles RR; Yang X; Fuson T; Cain RL; Zeng QQ; Chandrasekhar S; Emkey R; Xu Y; Thirunavukkarasu K; Bryant HU; Martin TJ
    J Pharmacol Exp Ther; 2004 Apr; 309(1):369-79. PubMed ID: 14718597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible.
    Kaynak D; Meffert R; Bostanci H; Günhan O; Ozkaya OG
    J Periodontol; 2003 Sep; 74(9):1348-54. PubMed ID: 14584869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment].
    Kaji H
    Clin Calcium; 2007 Dec; 17(12):1836-42. PubMed ID: 18057658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 19. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
    Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
    Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
    Shirota T; Tashiro M; Ohno K; Yamaguchi A
    J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.